Revvity announced that its Revvity Signals Software business has established a strategic partnership with Scitara – a prominent global provider of cloud-based solutions for the scientific industry.
Together, the companies will transform the way R&D teams work across the biotech, pharmaceutical and chemical industries with technology that accelerates digital transformation in the lab environment.
Revvity Signals Software has added a new “Signals Digital Lab Exchange” offering to its product portfolio that combines Scitara’s DLXTM technology with Revvity’s existing Signals platform to accelerate the flow of scientific data to-and-from the Revvity Signals Research Suite.
For Revvity Signals Research Suite customers, the new Scitara DLXTM capabilities are designed to enable customers to experience the advantages of seamless data mobility throughout their entire lab ecosystem. Revvity will be offering the Scitara DLX technology through its global sales, services and support team, providing customers an end-to-end solution.
“The transformative technologies we have brought together through this expanded relationship hold real power and potential for R&D teams looking to realize their vision of a truly connected modern lab,” commented Scitara CEO and Chairman Ajit Nagral.
“The wide adoption and expanding scope of the Revvity Signals Research Suite have exposed more research professionals to the Scitara cloud platform and user-friendly service suite, which in turn can boost productivity via true universal connectivity.
This expanded relationship further cements Scitara DLX’s position as the integration platform of choice for informatics and instrument vendors in our industry.”
